Find a Clinical Trial

Ipsen conducts first-in-the-world clinical trials to take science forward and bring innovative, new options to patients.

Alert Icon

The list below displays information about clinical trials sponsored by Ipsen.

Only interventional studies that have started within the last 20 years and completed within the 2 last years will be displayed.

The study results will be available on ClinicalTrials.gov from 12 months after the end of the study.

Filters

Condition

Status

Phase

Country

Showing : 15 of 144 clinical trials

Dysport

CzechiaCzechia

CanadaCanada

Netherlands (Kingdom of the)Netherlands (Kingdom of the)

Korea (the Republic of)Korea (the Republic of)

ItalyItaly

TurkeyTurkey

United States of America (the)United States of America (the)

PolandPoland

RomaniaRomania

PortugalPortugal

MalaysiaMalaysia


Terminated

Terminated

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic…

The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport® (AbobotulinumtoxinA) doses (600 units [U] and 800 U), compared to placebo in…

Urinary Incontinence

Overactive Bladder

Dysport

CzechiaCzechia

CanadaCanada

Netherlands (Kingdom of the)Netherlands (Kingdom of the)

Korea (the Republic of)Korea (the Republic of)

ItalyItaly

TurkeyTurkey

United States of America (the)United States of America (the)

PolandPoland

RomaniaRomania

PortugalPortugal

MalaysiaMalaysia


Terminated

Terminated

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic…

The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport® (AbobotulinumtoxinA) doses (600 units [U] and 800 U), compared to placebo in…

Prostate Cancer

Decapeptyl

BelgiumBelgium

SpainSpain

Netherlands (Kingdom of the)Netherlands (Kingdom of the)

LithuaniaLithuania

CzechiaCzechia

FranceFrance

GermanyGermany


Recruiting

Recruiting

Effects of triptorelin when given every 6-months under the skin…

The aim of the study is to determine if triptorelin formulated for use every 6 months (given twice during the study) is effective and safe for when given by injection…

Acromegaly

BIM23B065

BulgariaBulgaria

BelarusBelarus

HungaryHungary

UkraineUkraine

SerbiaSerbia

BelgiumBelgium


Terminated

Terminated

Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects…

The purpose of the protocol is evaluate the safety, the pharmacodynamics and the pharmacokinetic of repeated administration of BIM23B065 in subjects with acromegaly.

IPN10200

GermanyGermany

FranceFrance


Active, Not Recruiting

Active, Not Recruiting

A Study to Assess the Safety and Efficacy of IPN10200…

The purpose of this study is to assess the safety and efficacy profile of increasing doses of IPN10200 in comparison to placebo, with the aim to discover the doses(s) that…